COVID research prizes, CRISPR-like enzymes and a face-mask trial

DOI: https://doi.org/10.1038/d41586-021-02482-x

IF: 64.8

2021-09-15

Nature

Abstract:Nature, Published online: 15 September 2021; doi:10.1038/d41586-021-02482-xThe latest science news, in brief.

multidisciplinary sciences

What problem does this paper attempt to address?

Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches

Rocktotpal Konwarh

DOI: https://doi.org/10.3389/fmolb.2020.557377

IF: 6.113

2020-09-10

Frontiers in Molecular Biosciences

Abstract:The current global debacle of COVID-19, spelled by SARS-CoV-2 needs no elaboration. With incessant and constantly clambering number of deaths across various nations, the need of the hour is to develop readily deployable, fast, affordable detection assays and kits, yielding precise and consistent results as well as timely availability of efficacious anti-SARS-CoV-2 strategies to contain it. Conventionally employed real time PCR based technique for detection of the virus suffers from a couple of handicaps. Amongst other approaches, CRISPR based technology has ushered in new hopes. Recent efforts have been directed toward developing CRISPR/Cas based low-cost, rapid detection methods as well as development of one-pot assay platforms. The plausible application of CRISPR-Cas system to counteract the viral assault has also been assessed. The write up in this article mirrors the current status, the prospects and the practical snags of CRISPR/Cas technology for the detection and inactivation of the novel corona virus, SARS-CoV-2.

biochemistry & molecular biology
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics

Roaa Hadi,Abhishek Poddar,Shivakumar Sonnaila,Venkata Suryanarayana Murthy Bhavaraju,Shilpi Agrawal

DOI: https://doi.org/10.3390/cells13211794

IF: 6

2024-10-30

Cells

Abstract:Since the onset of the COVID-19 pandemic, a variety of diagnostic approaches, including RT-qPCR, RAPID, and LFA, have been adopted, with RT-qPCR emerging as the gold standard. However, a significant challenge in COVID-19 diagnostics is the wide range of symptoms presented by patients, necessitating early and accurate diagnosis for effective management. Although RT-qPCR is a precise molecular technique, it is not immune to false-negative results. In contrast, CRISPR-based detection methods for SARS-CoV-2 offer several advantages: they are cost-effective, time-efficient, highly sensitive, and specific, and they do not require sophisticated instruments. These methods also show promise for scalability, enabling diagnostic tests. CRISPR technology can be customized to target any genomic region of interest, making it a versatile tool with applications beyond diagnostics, including therapeutic development. The CRISPR/Cas systems provide precise gene targeting with immense potential for creating next-generation diagnostics and therapeutics. One of the key advantages of CRISPR/Cas-based therapeutics is the ability to perform multiplexing, where different sgRNAs or crRNAs can target multiple sites within the same gene, reducing the likelihood of viral escape mutants. Among the various CRISPR systems, CRISPR/Cas13 and CARVER (Cas13-assisted restriction of viral expression and readout) are particularly promising. These systems can target a broad range of single-stranded RNA viruses, making them suitable for the diagnosis and treatment of various viral diseases, including SARS-CoV-2. However, the efficacy and safety of CRISPR-based therapeutics must be thoroughly evaluated in pre-clinical and clinical settings. While CRISPR biotechnologies have not yet been fully harnessed to control the current COVID-19 pandemic, there is an optimism that the limitations of the CRISPR/Cas system can be overcome soon. This review discusses how CRISPR-based strategies can revolutionize disease diagnosis and therapeutic development, better preparing us for future viral threats.

cell biology
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics

Kok Gan Chan,Geik Yong Ang,Choo Yee Yu,Chan Yean Yean

DOI: https://doi.org/10.3390/life11111210

2021-11-09

Life

Abstract:The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global threat with an ever-increasing death toll even after a year on. Hence, the rapid identification of infected individuals with diagnostic tests continues to be crucial in the on-going effort to combat the spread of COVID-19. Viral nucleic acid detection via real-time reverse transcription polymerase chain reaction (rRT-PCR) or sequencing is regarded as the gold standard for COVID-19 diagnosis, but these technically intricate molecular tests are limited to centralized laboratories due to the highly specialized instrument and skilled personnel requirements. Based on the current development in the field of diagnostics, the programmable clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) system appears to be a promising technology that can be further explored to create rapid, cost-effective, sensitive, and specific diagnostic tools for both laboratory and point-of-care (POC) testing. Other than diagnostics, the potential application of the CRISPR–Cas system as an antiviral agent has also been gaining attention. In this review, we highlight the recent advances in CRISPR–Cas-based nucleic acid detection strategies and the application of CRISPR–Cas as a potential antiviral agent in the context of COVID-19.
CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics

Lang Zhou,Aleksandr L Simonian,Aleksandr L. Simonian

DOI: https://doi.org/10.1146/annurev-bioeng-081723-013033

IF: 11.324

2024-02-12

Annual Review of Biomedical Engineering

Abstract:The emergence of the COVID-19 pandemic has starkly exposed our significantly limited ability to promptly identify and respond to emergent biological threats. Consequently, there is an urgent need to advance biotechnological methods for addressing both known and unforeseen biological hazards. Recently, the CRISPR/Cas system has revolutionized genetic engineering, enabling precise and efficient synthetic biology applications. Therefore, this review aims to provide a comprehensive introduction to the fundamental principles underlying the CRISPR/Cas system and assess the advantages and limitations of various CRISPR/Cas-based techniques applicable to the detection of, defense against, and treatment of viral infections. These techniques include viral diagnostics, the development of antiviral vaccines, B cell engineering for antibody production, viral activation/interference, and epigenetic modifications. Furthermore, this review delves into the challenges and bioethical considerations associated with use of the CRISPR/Cas system. With the continuous evolution of technology, the CRISPR/Cas system holds considerable promise for addressing both existing and unforeseen biological threats. Expected final online publication date for the Annual Review of Biomedical Engineering, Volume 26 is May 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

engineering, biomedical
Panacea in progress: CRISPR and the future of its biological research introduction

Michael Carroll,Xiaohui Zhou

DOI: https://doi.org/10.1016/j.micres.2017.04.012

Abstract:The elucidation of the CRISPR (clustered, regularly interspaced, short palindromic repeats) adaptive immune system endogenous to most microbial life has culminated in progress in a diversity of scientific disciplines. The concurrently promising and eccentric nature of its theoretically plausible applications has wrought enthusiasm in the research community globally, potentiating advancements in human and animal health, ecological stability, and economic wellbeing, that would hitherto be considered the unattainable fancies of a futurist. It may be supposed that the tomes of science fiction are the true books of prophecy. Here, we narrate the scientific dialogue regarding CRISPR/Cas biotechnologies, from the happenstantial initial observation of the locus to the litany of intriguing contemporary endeavors. We discuss the mechanistic underpinnings in detail, and the corpulent body of literature on CRISPR-based biotech is digested into a germane and informative review. CRISPR applications such as microbiome engineering in order to enhance the human immune system beyond the fortitude of the wild type, bacterial genome editing in industrial and medical aspects, conquering antibiotic resistance, the development of novel antimicrobial techniques, the harvesting of solventogenic microbes, the development of antifungal therapies, and investigation of the genetic properties of fungi, are here represented, and the authors posit unconventional, and at times gainfully tangential, thoughts and concepts in order to encourage a reflective disposition towards this sophisticated device of nature: a panacea in progress, such that the most impassive and technical writing still carries the ring of poetry.
Discovery in CRISPR-Cas9 system.

Huali Zhang,Shaowei Pan

DOI: https://doi.org/10.11817/j.issn.1672-7347.2021.210169

2021-12-28

Abstract:The 2020 Nobel Prize in Chemistry was awarded to the American scientist Jennifer A. Doudna and the French scientist Emmanuelle Charpentier, in recognition of their discovery in one of the greatest weapons in genetic technology: CRISPR-Cas9 gene scissors. The CRISPR-Cas system is a bacterial defense immune system against exogenous genetic material. Because the system can specifically recognize and cut DNA, this technology is widely used for precise editing of animal, plant, and microbial DNA. The discovery of CRISPR-Cas9 gene scissors enables the tedious and complicated cell gene editing work to be completed in a few weeks or even less, which has promoted the development of gene editing technology in various fields and brought revolutionary influence to the field of life sciences. At the same time, CRISPR gene editing technology has become one of the new therapies for tumors because of its large number of targets and relatively simple operation, and it also makes gene therapy possible. Although the technology still needs to solve technical problems such as off-target and promoter inefficiency, the CRISPR-Cas system will show its unique advantages in more fields with the continuous development of life science and basic medicine.

Medicine,Chemistry
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement

Chao Li,Eleanor Brant,Hikmet Budak,Baohong Zhang

DOI: https://doi.org/10.1631/jzus.B2100009

2021-04-16

Abstract:Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.
Molecular simulations have boosted knowledge of CRISPR/Cas9: A Review

Angana Ray,Rosa Di Felice

DOI: https://doi.org/10.48550/arXiv.1904.06375

2019-04-12

Biological Physics

Abstract:Genome editing allows scientists to change an organism's DNA. One promising genome editing protocol, already validated in living organisms, is based on clustered regularly interspaced short palindromic repeats (CRISPR)/Cas protein-nucleic acid complexes. When the CRISPR/Cas approach was first demonstrated in 2012, its advantages with respect to previously available techniques, such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), immediately got attention and the method has seen a surge of experimental and computational investigations since then. However, the molecular mechanisms involved in target DNA recognition and cleavage are still not completely resolved and need further attention. The large size and complex nature of CRISPR/Cas9 complexes has been a challenge for computational studies, but some seed results exist and are illuminating on the cleavage activity. In this short review, we present recent progress in studying CRISPR/Cas9 systems by molecular dynamics simulations with coarse-grained and atomistic descriptions, including enhanced sampling.
Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Kun Chen,Ziyi Shen,Guanzhen Wang,Wei Gu,Shengchao Zhao,Zihan Lin,Wei Liu,Yi Cai,Gohar Mushtaq,Jia Jia,Tingdong Yan,Chunpeng (Craig) Wan

DOI: https://doi.org/10.3389/fbioe.2022.986233

IF: 5.7

2022-09-17

Frontiers in Bioengineering and Biotechnology

Abstract:CRISPR/Cas technology originated from the immune mechanism of archaea and bacteria and was awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing. Molecular diagnostics is highly valued globally for its development as a new generation of diagnostic technology. An increasing number of studies have shown that CRISPR/Cas technology can be integrated with biosensors and bioassays for molecular diagnostics. CRISPR-based detection has attracted much attention as highly specific and sensitive sensors with easily programmable and device-independent capabilities. The nucleic acid-based detection approach is one of the most sensitive and specific diagnostic methods. With further research, it holds promise for detecting other biomarkers such as small molecules and proteins. Therefore, it is worthwhile to explore the prospects of CRISPR technology in biosensing and summarize its application strategies in molecular diagnostics. This review provides a synopsis of CRISPR biosensing strategies and recent advances from nucleic acids to other non-nucleic small molecules or analytes such as proteins and presents the challenges and perspectives of CRISPR biosensors and bioassays.

multidisciplinary sciences
Research Progress in The Application of CRISPR Gene Editing Technology in Virus Detection and Treatment

Jinhui Pang

DOI: https://doi.org/10.54097/hset.v45i.7446

2023-04-18

Abstract:Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing (GE) technique is the latest generation of GE technology, which can carry out targeted and precise modification of the genome. In this article, a comparison of the Zinc-Finger Nucleases (ZFNs) , CRISPR/Cas and Transcription Activator-Like Effector Nucleases (TALENs) is presented, which indicates that CRISPR/Cas has significant advantages. For example, synthesis and screening are simpler and faster, and multiple genes can be edited simultaneously. To keep abreast of the times, current progress in the application of CRISPR in virus detection as well as treatment will be introduced in this paper. Firstly, CRISPR and its characteristics will be briefly introduced. Then the current application of CRISPR about detecting and treating viruses will be reviewed. Finally, the paper summarizes the shortcomings of CRISPR and looks forward to its future development.This article attempts to give readers a brief introduction to the emerging technology based on CRISPR and highlights its potential applications in virus detection and treatment.

Medicine
Funding CRISPR: Understanding the role of government and philanthropic institutions in supporting academic research within the CRISPR innovation system

David Fajardo-Ortiz,Stefan Hornbostel,Maywa Montenegro de Wit,Annie Shattuck

DOI: https://doi.org/10.1162/qss_a_00187

2022-04-15

Quantitative Science Studies

Abstract:Abstract CRISPR/Cas has the potential to revolutionize medicine, agriculture, and biology. Understanding the trajectory of CRISPR research, how it is influenced, and who pays for it is an essential research policy question. We use a combination of methods to map, via quantitative content analysis of CRISPR papers, the research funding profile of major government agencies and philanthropic organizations, and the networks involved in supporting key stages of high-influence research, namely basic biological research and technological development. The results of the content analysis show how the research supported by the main US government agencies focuses both on the study of CRISPR as a biological phenomenon and on its technological development and use as a biomedical research tool. US philanthropic organizations, with the exception of HHMI, tend, by contrast, to specialize in funding CRISPR as a genome editing technology. We present a model of cofunding networks at the two most prominent institutions for CRISPR/Cas research (the University of California and the Harvard/MIT/Broad Institute) to illuminate how philanthropic organizations have articulated with government agencies to cofinance the discovery and development of CRISPR/Cas. Our results raise fundamental questions about the role of the state and the influence of philanthropy over the trajectory of transformative technologies.

English Else
Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery

Alaa A.A. Aljabali,Mohamed El-Tanani,Murtaza M. Tambuwala

DOI: https://doi.org/10.1016/j.jddst.2024.105338

IF: 5

2024-02-01

Journal of Drug Delivery Science and Technology

Abstract:The rapid advancement of CRISPR-Cas9 technology has instigated a profound transformation in genome editing with significant implications for fields like health, agriculture, and biotechnology. This review provides an overview of the historical significance and fundamental components of CRISPR-Cas9, notably the Cas9 protein and guide RNA, underscoring its pivotal role in genetic manipulation. It emphasizes CRISPR-Cas9's preeminence in the domain of precise genome editing, driving breakthroughs in personalized medicine, gene therapy, and agriculture. Of paramount importance is the integration of nanomaterials, encompassing lipid-based and polymeric nanoparticles, alongside viral vectors, serving as potent vehicles for CRISPR-Cas9, augmenting delivery efficiency and precision. We explore strategies aimed at enhancing CRISPR-Cas9 through nanomaterials, while also addressing ethical and regulatory considerations. In the expert opinion section, we offer a nuanced perspective on the present state of the field, highlighting the potential for transformative progress in research and therapy. CRISPR-Cas9 stands on the brink of unlocking new possibilities in genome editing, providing innovative solutions to address pressing global challenges.

pharmacology & pharmacy
The new frontier of genome engineering with CRISPR-Cas9

Jennifer A Doudna,Emmanuelle Charpentier,Jennifer A. Doudna

DOI: https://doi.org/10.1126/science.1258096

IF: 56.9

2014-11-28

Science

Abstract:The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.

multidisciplinary sciences
A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease

Muhammad Farhat Ullah,Yasir Ali,Muhammad Ramzan Khan,Inam Ullah Khan,Bing Yan,M. Ijaz Khan,M.Y. Malik

DOI: https://doi.org/10.1016/j.sjbs.2021.10.020

IF: 4.052

2022-02-01

Saudi Journal of Biological Sciences

Abstract:The new coronavirus SARS-CoV-2 pandemic has put the world on lockdown for the first time in decades. This has wreaked havoc on the global economy, put additional burden on local and global public health resources, and, most importantly, jeopardised human health. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, and the CRISPR associated (Cas) protein (CRISPR/Cas) was identified to have structures in E. coli. The most modern of these systems is CRISPR/Cas. Editing the genomes of plants and animals took several years and cost hundreds of thousands of dollars until the CRISPR approach was discovered in 2012. As a result, CRISPR/Cas has piqued the scientific community's attention, particularly for disease diagnosis and treatment, because it is faster, less expensive, and more precise than previous genome editing technologies. Data from gene mutations in specific patients gathered using CRISPR/Cas can aid in the identification of the best treatment strategy for each patient, as well as other research domains such as coronavirus replication in cell culture, such as SARS-CoV2. The implications of the most prevalent driver mutations, on the other hand, are often unknown, making treatment interpretation difficult. For detecting a wide range of target genes, the CRISPR/Cas categories provide highly sensitive and selective tools. Genome-wide association studies are a relatively new strategy to discovering genes involved in human disease when it comes to the next steps in genomic research. Furthermore, CRISPR/Cas provides a method for modifying non-coding portions of the genome, which will help advance whole genome libraries by speeding up the analysis of these poorly defined parts of the genome.

biology
Editorial. CRISPR: 10 años de su descubrimiento, un Premio Nobel y en proceso, el aprendizaje de edición de genes

Javier Hernández Fernández

DOI: https://doi.org/10.21789/22561498.1896

2022-06-30

Revista Mutis

Abstract:El 28 de junio de 2012 seis autores publicaron el artículo A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity, con dos autoras para correspondencia: las genetistas Jennifer A. Doudna y Emmanuelle Charpentier, quienes recibieron el Premio Nobel de Química en 2020 por el descubrimiento. En esta década de investigación con Crispr (Clustered Regularly Interspaced Short Palindromic Repeats o, en español, Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas), ha evolucionado a tal punto de convertirse en uno de los hallazgos más importantes de la biología molecular moderna. Con la técnica desarrollada se puede hacer edición de genes o cirugía molecular o alteración del adn en humanos, plantas, animales y microorganismos.
Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

Farzaneh Zahedipour,Fatemeh Zahedipour,Parvin Zamani,Mahmoud Reza Jaafari,Amirhossein Sahebkar

DOI: https://doi.org/10.1016/j.virusres.2024.199314

IF: 6.286

2024-01-15

Virus Research

Abstract:The CRISPR/Cas system, identified as a type of bacterial adaptive immune system, have attracted significant attention due to its remarkable ability to precisely detect and eliminate foreign genetic material and nucleic acids. Expanding upon these inherent capabilities, recent investigations have unveiled the potential of reprogrammed CRISPR/Cas 9, 12, and 13 systems for treating viral infections associated with human diseases, specifically targeting DNA and RNA viruses, respectively. Of particular interest is the RNA virus responsible for the recent global outbreak of coronavirus disease 2019 (COVID-19), which presents a substantial public health risk, coupled with limited efficacy of current prophylactic and therapeutic techniques. In this regard, the utilization of CRISPR/Cas technology offers a promising gene editing approach to overcome the limitations of conventional methods in managing viral infections. This comprehensive review provides an overview of the latest CRISPR/Cas-based therapeutic and vaccine strategies employed to combat human viral infections. Additionally, we discuss significant challenges and offer insights into the future prospects of this cutting-edge gene editing technology.

virology
Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges

Asiya Batool,Fayaz Malik,Khurshid Iqbal Andrabi

DOI: https://doi.org/10.1007/s40291-020-00500-8

2020-11-13

Abstract:The emergence of the versatile gene-editing technology using programmable sequence-specific endonuclease system (CRISPR-Cas9) has instigated a major upheaval in biomedical research. In a brief span of time, CRISPR/Cas has been adopted by research labs around the globe because of its potential for significant progress and applicability in terms of efficiency, versatility and simplicity. It is a breakthrough technique for systematic genetic engineering, genome labelling, epigenetic and transcriptional modulation, and multiplexed gene editing, amongst others. This review provides an illustrative overview of the current research trends using CRISPR/Cas technology. We highlight the latest developments in CRISPR/Cas technique including CRISPR imaging, discovery of novel CRISPR systems, and applications in altering the genome, epigenome or RNA in different organisms. Finally, we address the potential challenges of this technique for its future use.

pharmacology & pharmacy,genetics & heredity
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms

Guillermo Aquino-Jarquin

DOI: https://doi.org/10.1016/j.drudis.2021.06.005

IF: 8.369

2021-08-01

Drug Discovery Today

Abstract:<p>The limitations of conventional diagnostic procedures, such as real-time PCR-based methods and serological tests, have led the scientific community to innovate alternative nucleic acid detection approaches for SARS-CoV-2 RNA, thereby addressing the dire need for increased testing. Such approaches aim to provide rapid, accurate, cost-effective, sensitive, and high-throughput detection of SARS-CoV-2 RNA, on multiple specimen types, and without specialized equipment and expertise. The CRISPR-Cas13 system functions as a sequence-specific RNA-sensing tool that has recently been harnessed to develop simplified and flexible testing formats. This review recapitulates technical advances in the most recent CRISPR-Cas13-based methods for SARS-CoV-2/COVID-19 diagnosis. The challenges and opportunities for implementing mass testing using these novel CRISPR-Cas13 platforms are critically analyzed.</p>

pharmacology & pharmacy
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

Jianli Tao,Daniel E. Bauer,Roberto Chiarle,Roberto Chiarle

DOI: https://doi.org/10.1038/s41467-023-35886-6

IF: 16.6

2023-01-13

Nature Communications

Abstract:CRISPR-Cas gene editing has revolutionized experimental molecular biology over the past decade and holds great promise for the treatment of human genetic diseases. Here we review the development of CRISPR-Cas9/Cas12/Cas13 nucleases, DNA base editors, prime editors, and RNA base editors, focusing on the assessment and improvement of their editing precision and safety, pushing the limit of editing specificity and efficiency. We summarize the capabilities and limitations of each CRISPR tool from DNA editing to RNA editing, and highlight the opportunities for future improvements and applications in basic research, as well as the therapeutic and clinical considerations for their use in patients.

multidisciplinary sciences
CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

Evguenia Kouranova,Kevin Forbes,Guojun Zhao,Joe Warren,Angela Bartels,Yumei Wu,Xiaoxia Cui

DOI: https://doi.org/10.1089/hum.2016.009

2016-06-01

Human Gene Therapy

Abstract:The rapid development of CRISPR technology greatly impacts the field of genetic engineering. The simplicity in design and generation of highly efficient CRISPR reagents allows more and more researchers to take on genome editing in different model systems in their own labs, even for those who found it daunting before. An active CRISPR complex contains a protein component (Cas9) and an RNA component (small guide RNA [sgRNA]), which can be delivered into cells in various formats. Cas9 can be introduced as a DNA expression plasmid, in vitro transcripts, or as a recombinant protein bound to the RNA portion in a ribonucleoprotein particle (RNP), whereas the sgRNA can be delivered either expressed as a DNA plasmid or as an in vitro transcript. Here we compared the different delivery methods in cultured cell lines as well as mouse and rat single-cell embryos and view the RNPs as the most convenient and efficient to use. We also report the detection of limited off-targeting in cells and embryos and discuss approaches to lower that chance. We hope that researchers new to CRISPR find our results helpful to their adaptation of the technology for optimal gene editing.

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology

COVID research prizes, CRISPR-like enzymes and a face-mask trial

Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches

Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics

CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics

Panacea in progress: CRISPR and the future of its biological research introduction

Discovery in CRISPR-Cas9 system.

CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement

Molecular simulations have boosted knowledge of CRISPR/Cas9: A Review

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

Research Progress in The Application of CRISPR Gene Editing Technology in Virus Detection and Treatment

Funding CRISPR: Understanding the role of government and philanthropic institutions in supporting academic research within the CRISPR innovation system

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery

The new frontier of genome engineering with CRISPR-Cas9

A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease

Editorial. CRISPR: 10 años de su descubrimiento, un Premio Nobel y en proceso, el aprendizaje de edición de genes

Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges

Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos